Cadrenal Therapeutics Inc - fluxo de caixa (NASDAQ:CVKD) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -60-3.53 M-7.36 M-12.6 M -12.6 M Cash from investing activities —-3 254-6 537-5 104 -5 104 Cash from financing activities —11.9 M8.98 M6.6 M 6.6 M Free cash flow -60-3.53 M-7.36 M-12.61 M -12.61 M

Notícias

Cadrenal registra prejuízo no 4º trimestre e conclui reunião com FDA sobre terapia para HIT

Cadrenal schedules FDA meeting for HIT drug CAD-1005

Ações da Cadrenal Therapeutics disparam com resultados de ensaio de Fase 2

Cadrenal Therapeutics stock surges on Phase 2 trial results

CAD-1005 da Cadrenal reduz coágulos sanguíneos em estudo sobre TIH

Cadrenal’s CAD-1005 shows reduction in blood clots in HIT trial

Cadrenal destaca potencial de inibidor 12-LOX para distúrbio sanguíneo

Cadrenal highlights potential of 12-LOX inhibitor for blood disorder

Cadrenal Therapeutics acquires first-in-class HIT treatment from Veralox

Cadrenal Therapeutics appoints PTC Therapeutics CMO to board

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc.